Aim Immunotech Inc AIM

$0.18 -0.01 (-4.10%)

Valuation

Market cap
5,714,000
Revenue TTM
$90,000
Net income TTM
$-13,960,000
PE ratio
0.00
Forward PE
—
Profit margin
-15,511.11%
Debt to equity
0.00

Trading

Volume
1,331,500
Avg volume
5,853,960
Day's range
$0.18 – $0.19
Shares out
30,442,000
Stochastic %K
28%
Beta
1.27
Analysts
Sell
Price target
$4.25

Price

Company profile

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa)...

Show more

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. It is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.

Industry
Biotechnology
Sector
Healthcare
Phone
352 448 7797
Website
https://aimimmuno.com
Address
2117 SW Highway 484, Ocala, United States

Latest news

Stocktwits

TraderBuckNKY Oct 2, 5:28 PM
$AIM ...and, maybe not....
1 replies
DENDOG57 Oct 2, 8:22 AM
$AIM been a long wait, about to hit finally... $$$
0 replies
Stock_Catcher Oct 2, 1:58 AM
Money Friday Watchlist My Scans $HTZ $AIM $GALT $ALT $PFSA
0 replies
MAJTom Oct 1, 8:03 PM
$AIM and a little more here
0 replies
MAJTom Oct 1, 6:43 PM
$AIM yep. Bought more. Worth it
0 replies
MAJTom Oct 1, 6:37 PM
$AIM show me Christine
0 replies
jonjonson1234 Oct 1, 2:59 PM
$AIM When was the last time that a press release from this company prestented some actual news rather than just repeating stale pumps?
1 replies
AIM_ImmunoTech Oct 1, 1:13 PM
$AIM Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data https://aimimmuno.com/aim-immunotech-spotlights-growing-attention-around-ampligen-pancreatic-cancer-strategy-as-duripanc-advances-toward-topline-data/
1 replies